MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-23-2025
West Pharmaceutical Services Cash and Cash Equivalents 2011-2026 | WST
Annual Cash and Cash Equivalents West Pharmaceutical Services
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 485 M | 854 M | 894 M | 763 M | 616 M | 439 M | 337 M | 236 M | 203 M | 275 M | 255 M | 230 M | 162 M | 91.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 894 M | 91.8 M | 417 M |
Quarterly Cash and Cash Equivalents West Pharmaceutical Services
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 628 M | 510 M | 404 M | 485 M | 491 M | 446 M | 602 M | 854 M | 899 M | 796 M | 886 M | 894 M | 729 M | 718 M | 668 M | 763 M | 688 M | 576 M | 484 M | 616 M | 616 M | 616 M | 616 M | 439 M | 439 M | 439 M | 439 M | 337 M | 337 M | 337 M | 337 M | 236 M | 236 M | 236 M | 236 M | 203 M | 203 M | 203 M | 203 M | 275 M | 275 M | 275 M | 275 M | 255 M | 255 M | 255 M | 255 M | 230 M | 230 M | 230 M | 230 M | 162 M | 162 M | 162 M | 162 M | 91.8 M | 91.8 M | 91.8 M | 91.8 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 899 M | 91.8 M | 405 M |
Cash and Cash Equivalents of other stocks in the Medical instruments industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
3.56 M | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
1.76 B | $ 20.95 | 1.21 % | $ 10.7 B | USA |
 |
Becton, Dickinson and Company
BDX
|
641 M | $ 203.51 | -0.78 % | $ 58.5 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
6.49 M | $ 8.27 | 0.98 % | $ 167 M | USA |
 |
Alcon
ALC
|
1.68 B | $ 79.9 | -0.91 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
309 M | $ 151.28 | -0.24 % | $ 3.69 B | USA |
 |
AtriCure
ATRC
|
123 M | $ 42.16 | -0.58 % | $ 1.98 B | USA |
 |
iRhythm Technologies
IRTC
|
420 M | $ 187.98 | -0.67 % | $ 5.86 B | USA |
 |
electroCore
ECOR
|
10.3 M | $ 5.1 | 1.39 % | $ 28.1 K | USA |
 |
Haemonetics Corporation
HAE
|
307 M | $ 83.99 | -0.05 % | $ 4.23 B | USA |
 |
AngioDynamics
ANGO
|
55.9 M | $ 10.01 | -0.4 % | $ 409 M | USA |
 |
Harvard Bioscience
HBIO
|
4.28 M | $ 0.67 | 2.7 % | $ 28.4 M | USA |
 |
Repro Med Systems
KRMD
|
11.5 M | $ 5.81 | -0.08 % | $ 265 M | USA |
 |
The Cooper Companies
COO
|
111 M | $ 82.78 | -0.43 % | $ 16.5 B | USA |
 |
LeMaitre Vascular
LMAT
|
25.6 M | $ 85.15 | 0.13 % | $ 1.91 B | USA |
 |
Masimo Corporation
MASI
|
178 M | $ 137.3 | -0.44 % | $ 7.32 B | USA |
 |
Glaukos Corporation
GKOS
|
93.5 M | $ 113.5 | -0.63 % | $ 5.5 B | USA |
 |
Merit Medical Systems
MMSI
|
377 M | $ 89.12 | -4.36 % | $ 5.19 B | USA |
 |
InfuSystem Holdings
INFU
|
165 K | $ 8.97 | 0.28 % | $ 185 M | USA |
 |
Isoray
ISR
|
61.6 M | - | 0.03 % | $ 108 M | USA |
 |
Nephros
NEPH
|
4.31 M | $ 5.01 | - | $ 52 M | USA |
 |
Intuitive Surgical
ISRG
|
2.03 B | $ 587.36 | 0.39 % | $ 209 B | USA |
 |
Predictive Oncology
POAI
|
735 K | $ 7.04 | 4.15 % | $ 38.4 M | USA |
 |
Microbot Medical
MBOT
|
2.47 M | $ 2.17 | -1.14 % | $ 22.1 M |  Israel |
 |
Milestone Scientific
MLSS
|
3.26 M | $ 0.29 | -0.75 % | $ 23.1 M | USA |
 |
NeuroMetrix
NURO
|
1.43 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.07 B | $ 23.54 | -0.28 % | $ 4.05 B | USA |
 |
OraSure Technologies
OSUR
|
268 M | $ 2.65 | -0.38 % | $ 197 M | USA |
 |
Utah Medical Products
UTMD
|
92.9 M | $ 59.13 | 0.69 % | $ 215 M | USA |
 |
Pro-Dex
PDEX
|
419 K | $ 41.55 | 0.61 % | $ 137 M | USA |
 |
Pulse Biosciences
PLSE
|
44.4 M | $ 15.08 | 2.41 % | $ 724 M | USA |
 |
Repligen Corporation
RGEN
|
751 M | $ 167.44 | 0.61 % | $ 9.33 M | USA |
 |
ResMed
RMD
|
274 M | $ 251.02 | 0.04 % | $ 36.7 B | USA |
 |
BioLife Solutions
BLFS
|
95.4 M | $ 24.96 | 0.02 % | $ 1.15 B | USA |
 |
STERIS plc
STE
|
172 M | $ 260.69 | - | $ 25.7 B | USA |
 |
Stereotaxis
STXS
|
19.8 M | $ 2.58 | -0.19 % | $ 208 M | USA |
 |
Retractable Technologies
RVP
|
4.24 M | $ 0.78 | - | $ 23.4 M | USA |
 |
STAAR Surgical Company
STAA
|
144 M | $ 22.38 | -0.53 % | $ 1.1 B | USA |
 |
Teleflex Incorporated
TFX
|
290 M | $ 110.92 | 0.83 % | $ 5.2 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
272 M | $ 12.45 | -0.36 % | $ 2.53 B | USA |